Cytodel
Gordon Beck has been working as a SAGE Advisor at SAGE - Innosphere Ventures since January 2024. Prior to this role, Gordon was the Operations Director at CYTODEL Inc starting in December 2017. Gordon also holds the position of Principal Consultant at GB4BD LLC since October 2011.
This person is not in any teams
This person is not in any offices
Cytodel
1 followers
Cytodel, Inc. ® is a biopharmaceutical company that uses the tools of 21st-century molecular biology to produce recombinant derivatives of botulinum neurotoxin.